Histamine H4 Receptor Antagonist Ameliorates the Progression of Experimental Autoimmune Encephalomyelitis via Regulation of T-Cell Imbalance

Histamine H4 Receptor Antagonist Ameliorates the Progression of Experimental Autoimmune Encephalomyelitis via Regulation of T-Cell Imbalance

Multiple sclerosis (MS) is a degenerative condition characterized by immune-mediated attacks on the central nervous system (CNS), resulting in demyelination and recurring T-cell responses. The histamine H4 receptor (H4R) is mainly expressed in cellular populations and plays a vital role in inflammat...

Full description

Bibliographic Details
Main Authors:	Abdullah A. Aldossari, Mohammed A. Assiri, Mushtaq A. Ansari, Ahmed Nadeem, Sabry M. Attia, Saleh A. Bakheet, Thamer H. Albekairi, Hatun A. Alomar, Haneen A. Al-Mazroua, Taghreed N. Almanaa, Mohammed A. Al-Hamamah, Mohammad Y. Alwetaid, Sheikh F. Ahmad
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Series:	International Journal of Molecular Sciences
Subjects:	H4R antagonist JNJ 10191584 EAE multiple sclerosis inflammatory mediators transcription factors
Online Access:	https://www.mdpi.com/1422-0067/24/20/15273

Similar Items

Histamine H4 Receptor Agonist, 4-Methylhistamine, Aggravates Disease Progression and Promotes Pro-Inflammatory Signaling in B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model
by: Abdulaziz M. S. Alsaad, et al.
Published: (2023-08-01)

A Selective Histamine H4 Receptor Antagonist, JNJ7777120, Role on glutamate Transporter Activity in Chronic Depression
by: Yesim Yeni, et al.
Published: (2022-02-01)

DAPTA, a C-C Chemokine Receptor 5 (CCR5), Leads to the Downregulation of Notch/NF-κB Signaling and Proinflammatory Mediators in CD40<sup>+</sup> Cells in Experimental Autoimmune Encephalomyelitis Model in SJL/J Mice
by: Hanan Alghibiwi, et al.
Published: (2023-05-01)

The Exposure to Lead (Pb) Exacerbates Immunological Abnormalities in BTBR T<sup>+</sup> Itpr<sup>3tf</sup>/J Mice through the Regulation of Signaling Pathways Relevant to T Cells
by: Mohammed A. Assiri, et al.
Published: (2023-11-01)

Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections
by: Jones TM, et al.
Published: (2016-06-01)

Novel Therapeutic Insights in Dedifferentiated Liposarcoma: A Role for FGFR and MDM2 Dual Targeting
by: Bérengère Dadone-Montaudié, et al.
Published: (2020-10-01)

Cadmium Exposure Is Associated with Behavioral Deficits and Neuroimmune Dysfunction in BTBR T<sup>+</sup> Itpr3tf/J Mice
by: Mohammed M. Alanazi, et al.
Published: (2023-03-01)

Clozapine reduces infiltration into the CNS by targeting migration in experimental autoimmune encephalomyelitis
by: Katharina Robichon, et al.
Published: (2020-02-01)

Pertussis vaccine-induced experimental autoimmune encephalomyelitis in mice
by: Stojković Aleksandra, et al.
Published: (2014-03-01)

Amelioration of experimental autoimmune encephalomyelitis by clozapine is not associated with defective CD4 T cell responses
by: Pirooz Zareie, et al.
Published: (2017-03-01)

Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis
by: Müller André, et al.
Published: (2012-03-01)

Glial pathology and retinal neurotoxicity in the anterior visual pathway in experimental autoimmune encephalomyelitis
by: Jing Jin, et al.
Published: (2019-07-01)

A method for histopathological study of the multifocal nature of spinal cord lesions in murine experimental autoimmune encephalomyelitis
by: Katherine N. Gibson-Corley, et al.
Published: (2016-01-01)

Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs
by: Chung-Pu Wu, et al.
Published: (2020-05-01)

The Dual Immunoregulatory function of Nlrp12 in T Cell-Mediated Immune Response: Lessons from Experimental Autoimmune Encephalomyelitis
by: Marjan Gharagozloo, et al.
Published: (2018-08-01)

Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis
by: Henrique Lemos, et al.
Published: (2020-06-01)

Rat Ovarian Function Is Impaired during Experimental Autoimmune Encephalomyelitis
by: Ana Milosevic, et al.
Published: (2023-03-01)

Lowering blood cholesterol does not affect neuroinflammation in experimental autoimmune encephalomyelitis
by: Solenne Vigne, et al.
Published: (2022-02-01)

Early treatment with JNJ-46356479, a mGluR2 modulator, improves behavioral and neuropathological deficits in a postnatal ketamine mouse model of schizophrenia
by: A. Martínez-Pinteño, et al.
Published: (2023-02-01)

JNJ-64619178 radiosensitizes and suppresses fractionated ionizing radiation-induced neuroendocrine differentiation (NED) in prostate cancer
by: Jogendra Singh Pawar, et al.
Published: (2023-03-01)

Changes of B cell subsets in central pathological process of autoimmune encephalomyelitis in mice
by: Yingqiong Xiong, et al.
Published: (2019-07-01)

Spatiotemporal resolution of spinal meningeal and parenchymal inflammation during experimental autoimmune encephalomyelitis
by: Bandana Shrestha, et al.
Published: (2017-12-01)

The Receptor Tyrosine Kinase c-Met Promotes Lipid Accumulation in 3T3-L1 Adipocytes
by: Yu-Kyoung Park, et al.
Published: (2023-04-01)

Virology analysis in HCV genotype 1-infected patients treated with the combination of simeprevir and TMC647055/ritonavir, with and without ribavirin, and JNJ-56914845
by: Leen Vijgen, et al.
Published: (2017-05-01)

Autoantibody–Abzymes with Catalase Activity in Experimental Autoimmune Encephalomyelitis Mice
by: Andrey E. Urusov, et al.
Published: (2023-01-01)

Characterization of Neurochemical Signature Alterations in the Enteric Nervous System in Autoimmune Encephalomyelitis
by: Julia Kicherer, et al.
Published: (2022-06-01)

Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model
by: Anna T. Wilmes, et al.
Published: (2018-06-01)

Anti-Axl antibody treatment reduces the severity of experimental autoimmune encephalomyelitis
by: Juwen C. DuBois, et al.
Published: (2020-10-01)

Fibrotic scar after experimental autoimmune encephalomyelitis inhibits oligodendrocyte differentiation
by: Stephanie L. Yahn, et al.
Published: (2020-02-01)

Correlation of gut microbiota composition with resistance to experimental autoimmune encephalomyelitis in rats
by: Suzana Stanisavljevic, et al.
Published: (2016-12-01)

Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis
by: Ping-Chang Kuo, et al.
Published: (2020-04-01)

Hormones in experimental autoimmune encephalomyelitis (EAE) animal models
by: Ghareghani Majid, et al.
Published: (2021-05-01)

Astragaloside IV inhibits experimental autoimmune encephalomyelitis by modulating the polarization of both microglia/macrophages and astrocytes
by: Jingwen Yu, et al.
Published: (2023-07-01)

Advantages and limitations of experimental autoimmune encephalomyelitis in breaking down the role of the gut microbiome in multiple sclerosis
by: Esther Melamed, et al.
Published: (2022-11-01)

Upregulation of C-X-C motif chemokine 12 in the spinal cord alleviated the symptoms of experimental autoimmune encephalomyelitis in Lewis rats
by: Dahe Lin, et al.
Published: (2023-03-01)

Modulation of fibronectin expression in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis
by: De-Carvalho M.C.A., et al.
Published: (1999-01-01)

Silybin Alleviates Experimental Autoimmune Encephalomyelitis by Suppressing Dendritic Cell Activation and Th17 Cell Differentiation
by: Huan-Li Yang, et al.
Published: (2021-09-01)

Emerging Role of Follicular T Helper Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
by: James L. Quinn, et al.
Published: (2018-10-01)

CXCR7 antagonism prevents axonal injury during experimental autoimmune encephalomyelitis as revealed by <it>in vivo </it>axial diffusivity
by: Cruz-Orengo Lillian, et al.
Published: (2011-12-01)

Inhibition of the NLRP3 Inflammasome Activation by Manoalide Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis
by: Cong Li, et al.
Published: (2022-02-01)